HOLX vs. SONVY: Which Stock Should Value Investors Buy Now?

Core Viewpoint - Hologic (HOLX) is currently more attractive to value investors compared to SONOVA HOLDING (SONVY) based on various valuation metrics and earnings estimate revisions [3][7]. Valuation Metrics - Hologic has a forward P/E ratio of 16.64, while SONVY has a higher forward P/E of 21.56 [5]. - The PEG ratio for Hologic is 2.13, indicating a more favorable valuation in relation to its expected earnings growth compared to SONVY's PEG ratio of 3.27 [5]. - Hologic's P/B ratio stands at 3.3, significantly lower than SONVY's P/B ratio of 5.13, suggesting that Hologic is undervalued relative to its book value [6]. Analyst Outlook - Hologic holds a Zacks Rank of 2 (Buy), indicating a positive analyst outlook, while SONVY has a Zacks Rank of 4 (Sell), reflecting a less favorable outlook [3]. - The stronger estimate revision activity for Hologic further supports its position as a more attractive investment option for value investors [7].